CONMED CORPORATION (NASDAQ:CNMD) Files An 8-K Results of Operations and Financial Condition
Item 2.02
|
Results of Operations and Financial Condition. |
On February 1, 2017, CONMED Corporation issued a press release
announcing financial results for the fourth quarter of 2016. A
copy of this press release is attached hereto as Exhibit 99.1.
The information in this Current Report on Form 8-K that is
furnished under Item 2.02. Results of Operations and Financial
Condition and Exhibit 99.1 attached hereto shall not be deemed
filed for purposes of Section 18 of the Securities Act of 1934,
nor shall they be deemed incorporated by reference in any filing
under the Securities Act of 1933, except as shall be expressly
set forth by specific reference in such filing.
| Section 9 | Financial Statements and Exhibits |
| Item 9.01 | Financial Statements and Exhibits. |
| (c) | Exhibits |
The following exhibit is included herewith:
| Exhibit No. | Description of Exhibit | |
| 99.1 |
Press Release dated February 1, 2017, issued by CONMED Corporation. |
About CONMED CORPORATION (NASDAQ:CNMD)
CONMED Corporation is a medical technology company. The Company is engaged in the development, manufacturing and sale on a global basis of surgical devices and related equipment. Its products are used by surgeons and physicians in a range of specialties, including orthopedics, general surgery, gynecology, neurosurgery and gastroenterology. Its product lines consist of orthopedic surgery, general surgery and surgical visualization. Its orthopedic surgery product lines include sports medicine, powered surgical instruments, and sports biologics and tissue. Its general surgery product line offers a range of products in the areas of advanced surgical, endoscopic technologies and critical care. Its surgical visualization product line offers imaging systems for use in minimally invasive orthopedic and general surgery procedures. Its products are distributed domestically directly to over 6,000 hospitals and other healthcare institutions, as well as through medical specialty distributors. CONMED CORPORATION (NASDAQ:CNMD) Recent Trading Information
CONMED CORPORATION (NASDAQ:CNMD) closed its last trading session down -2.56 at 41.71 with 252,514 shares trading hands.